Cancer Research
Beta-Hydroxybutyrate Boosts CAR T Cell Cancer Fighting Power
Ketogenic diet metabolite enhances CAR T cell metabolism and tumor control in multiple cancer models
Research Paper
Apr 5, 2026 0
Results for "Hyperbaric Oxygen Therapy" in Cancer
20 articles
Cancer Research
High-Intensity Exercise During Bladder Cancer Treatment Shows Promise in BRAVE Trial
First study tests whether supervised exercise training is safe and beneficial for bladder cancer patients during treatment.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Blocking Haem Signaling Revives Exhausted Cancer-Fighting T Cells
Scientists identify a mitochondria-proteasome-haem pathway that silences immune cells — and show bortezomib can fix it in CAR-T therapy.
Research Paper
Jun 22, 2026 0
Cancer Research
HBO1 Protein Drives Cancer Spread and Immunotherapy Resistance in Ovarian Cancer
New research identifies HBO1 as a key driver of cancer cell transformation and resistance to CAR-T cell therapy in ovarian cancer.
Research Paper
Apr 9, 2026 0
Cancer Research
Physical Therapy and Relaxation Techniques Boost Resilience in Older Lung Cancer Patients
A completed pilot trial tested physical therapy and progressive muscle relaxation to preserve function and mood in older adults with advanced lung cancer.
Clinical Trial
May 12, 2026 0
Cancer Research
Blood-Brain Barrier Breakthrough Could Transform Brain Cancer Immunotherapy Delivery
New research reveals how brain barrier variations affect cancer treatment delivery, potentially improving outcomes.
Research Paper
Mar 29, 2026 0
Cancer Research
Blood-Brain Barrier Variations Could Transform Brain Cancer Immunotherapy Delivery
New research reveals how blood-brain barrier differences affect immunotherapy access, potentially improving brain cancer treatment.
Research Paper
Mar 29, 2026 0
Cancer Research
BCG Bladder Cancer Treatment Reprograms Bone Marrow to Boost Tumor Immunity
BCG therapy for bladder cancer travels to bone marrow, reprogramming stem cells to produce enhanced immune cells that fight tumors throughout the body.
Research Paper
Apr 2, 2026 0
Cancer Research
Lipid Molecule 12-HETE Found to Cripple Immune Cells in Liver Cancer
A newly identified lipid mediator may explain why immune cells fail to fight MASH-driven liver cancer, opening therapeutic targets.
Research Paper
May 21, 2026 0
Cancer Research
New Triple Drug Combo Doubles Survival for Brain Metastases in HER2+ Breast Cancer
Tucatinib-based treatment extends survival from 4.4 to 10 months for women with breast cancer that spread to brain lining.
Research Paper
Mar 28, 2026 0
Cancer Research
AI Model Predicts Liver Cancer Outcomes Using Oxygen and Immune Markers
New fusion model combines hypoxia and immune markers to predict hepatocellular carcinoma treatment success non-invasively.
Research Paper
Apr 4, 2026 0
Cancer Research
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Clinical Trial
May 25, 2026 0
Cancer Research
Radiation Therapy Rivals Surgery for Early-Stage Liver Cancer in Largest Study Yet
A multinational study of 4,913 patients finds EBRT delivers survival outcomes comparable to surgery and ablation for early hepatocellular carcinoma.
Research Paper
May 19, 2026 0
Cancer Research
Chemotherapy Plus Hormones vs Hormones Alone for Older Women with High-Risk Breast Cancer
ASTER 70s trial compares treatment intensities for women 70+ with genomically high-risk breast cancer to optimize outcomes while minimizing toxicity.
Research Paper
Apr 4, 2026 0
Cancer Research
Novel Cancer Treatment Combines Surgery with Direct Immune Therapy Delivery
French researchers test intraperitoneal nivolumab after surgery and heated chemotherapy for advanced ovarian cancer patients.
Clinical Trial
Mar 28, 2026 0
Cancer Research
16-Week Holistic Program Boosts Quality of Life in Cancer Survivors
A pilot trial tested a comprehensive physical, mental, and spiritual intervention for cancer survivors, tracking outcomes at 6 months post-program.
Clinical Trial
May 28, 2026 0
Cancer Research
PARP Inhibitor Rechallenge Shows Promise for Recurrent Ovarian Cancer Treatment
New study reveals combining PARP inhibitors with bevacizumab extends progression-free survival in previously treated ovarian cancer patients.
Research Paper
Mar 29, 2026 0
Cancer Research
High-Intensity Exercise Shows Promise for Men with Early-Stage Prostate Cancer
HIIT training studied in 52 men with prostate cancer on active surveillance to evaluate exercise benefits during watchful waiting.
Clinical Trial
Mar 29, 2026 1
Cancer Research
Blue Light Surgery Cuts Bladder Cancer Recurrence by Up to 32% in High-Risk Patients
A Cochrane meta-analysis of 17 RCTs finds blue light TURBT reduces bladder cancer recurrence and progression, especially in intermediate- and high-risk patients.
Review
Jun 13, 2026 0
Cancer Research
Immunotherapy Plus T-DXd Shows Strong Results in HER2-Low Breast Cancer
The BEGONIA trial finds durvalumab combined with trastuzumab deruxtecan achieves 62% response rate in hard-to-treat metastatic breast cancer.
Research Paper
Jun 9, 2026 0
Page 1 of 2Next